Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 2/2013

01-05-2013 | Letter to the Editors

Unmasking the Janus face of the association between psoriasis, metabolic syndrome and obstructive sleep apnea

Authors: Maria Dalamaga, Evangelia Papadavid, Katerina Vlami

Published in: Sleep and Breathing | Issue 2/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK (2006) Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003–2006. Arch Dermatol 147:419–424CrossRef
2.
Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM (2011) Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 132:556–562PubMedCrossRef
3.
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735–1741PubMedCrossRef
4.
Kim N, Thrash B, Menter A (2010) Comorbidities in psoriasis patients. Semin Cutan Med Surg 29:10–15PubMedCrossRef
5.
Buslau M, Benotmane K (1999) Cardiovascular complication of psoriasis: Does obstructive sleep apnea play a role? Acta Dermatol Venerol 79:234CrossRef
6.
Papadavid E, Vlami K, Dalamaga M, Giatrakou S, Theodoropoulos K, Gyftopoulos S, Stavrianeas N, Papiris S, Rigopoulos D (2012) Sleep apnea as a comorbidity in obese psoriasis patients: a cross sectional study. Do psoriasis characteristics and metabolic parameters play a role? J Eur Acad Dermatol Venereol. doi:10.1111/j.1468-3083.2012.04580.x. PMID 22620285
7.
Karaca S, Fidan F, Erkan F, Nural S, Pinarcı T, Gunay E, Unlu M (2012) Might psoriasis be a risk factor for obstructive sleep apnea syndrome? Sleep Breath. doi:10.​1007/​s11325-012-0686-2
8.
Thorburn PT, Riha RL (2010) Skin disorders and sleep in adults: where is the evidence? Sleep Med Rev 14:351–358PubMedCrossRef
9.
Gowda S, Goldblum OM, McCall WV, Feldman SR (2010) Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 63:114–123PubMedCrossRef
10.
Yang YW, Kang JH, Lin HC (2012) Increased risk of psoriasis following obstructive sleep apnea: a longitudinal population-based study. Sleep Med 13:285–289PubMedCrossRef
Metadata
Title
Unmasking the Janus face of the association between psoriasis, metabolic syndrome and obstructive sleep apnea
Authors
Maria Dalamaga
Evangelia Papadavid
Katerina Vlami
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-012-0749-4

Other articles of this Issue 2/2013

Sleep and Breathing 2/2013 Go to the issue

Original Article

The impact of sleep duration in obstructive sleep apnea patients

Original Article

Depressive symptoms in patients with obstructive sleep apnea/hypopnea syndrome

Original Article

Sleep medicine knowledge, attitudes, and practices among medical students in Guangzhou, China

Letter to the Editors

Obstructive sleep apnea and dyslipidemia: importance of the liver axis

Original Article

Usefulness of the Berlin Questionnaire to identify patients at high risk for obstructive sleep apnea: a population-based door-to-door study

Original Article

Manual vs. automated analysis of polysomnographic recordings in patients with chronic obstructive pulmonary disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits